Total Funding
84
73
Total FundingVenture - Series Unknown raised
Growth Score 84 in past quarter
-9 pts
Heat Score 73 in past quarter
-14 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
55722
AnnJi Pharmaceutical is a drug development company that produces small molecules for neurology, dermatology, and inflammatory disorders.
- Wendy Huang: CEO
- Ye Junyan: Chief Financial Officer
About the Company
AnnJi Pharmaceutical is a clinical-stage drug development company that specializes in developing small molecules that address unmet medical needs in the areas of neurology, dermatology, and inflammatory disorders, including rare diseases such as idiopathic pulmonary fibrosis and Kennedy’s disease, and SBMA (Spinal and bulbar muscular atrophy). The
focus of the company is on creating global collaborations and business partnerships in the late-stage product development and commercialization of pharmaceutical drugs.